Commonwealth Equity Services, LLC Castle Biosciences Inc Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$13.28 - $20.3 $53,412 - $81,646	-4,022 Reduced 26.29%	11,274 $190,000
Q2 2023 Aug 10, 2023	BUY	$11.66 - $26.0 $178,351 - $397,696	15,296 New	15,296 $210,000
Q2 2022 Jul 19, 2022	SELL	$16.0 - $45.99 $73,648 - $211,691	-4,603 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$33.17 - $46.98 $152,681 - $216,248	4,603 New	4,603 $206,000
Q4 2021 Jan 31, 2022	SELL	$39.06 - $67.58 $198,073 - $342,698	-5,071 Closed	0 $0

Q3 2021 Oct 29, 2021	SELL	$60.13 - $77.6 $360 - $465	-6 Reduced 0.12%	5,071 $337,000
Q2 2021 Aug 11, 2021	BUY	$50.07 - $76.78 $60,084 - $92,136	1,200 Added 30.95%	5,077 $372,000
Q1 2021 May 04, 2021	BUY	$58.92 - $97.33 $228,432 - $377,348	3,877 New	3,877 $265,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.